[1]
“Method Development and Validation of Latanoprost by using RP-HPLC in Pharmaceutical Formulations”, IJRAPS, vol. 7, no. 4, pp. 14–16, Apr. 2023, doi: 10.47070/ijraps.v7i4.142.